Open Access Pre-publication history

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer

Nobumichi Tanaka*, Isao Asakawa, Kiyohide Fujimoto, Satoshi Anai, Akihide Hirayama, Masatoshi Hasegawa, Noboru Konishi and Yoshihiko Hirao

BMC Urology 2012, 12:28  doi:10.1186/1471-2490-12-28

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 17 Apr 2012
Reviewer's Report Jonathan Izawa 18 May 2012
Reviewer's Report Peter Black 09 Jun 2012
Resubmission - Version 2 Manuscript Author's comment 02 Aug 2012
Resubmission - Version 3 09 Aug 2012
Resubmission - Version 4 Manuscript 22 Aug 2012
Resubmission - Version 5 Manuscript Author's comment 06 Sep 2012
Editorial acceptance 11 Sep 2012
Published 14 Sep 2012